Ovarian cancer, Solid tumor/s, Cancer, Platinum-resistant ovarian cancer
DiscontinuedStock, pipeline and biotech catalyst intelligence
Clinical portfolio
| Asset | Indication | Stage | Milestone | Signals ? |
|---|---|---|---|---|
| Nemvaleukin alfa + pembrolizumab | Ovarian cancer, Solid tumor/s, Cancer, Platinum-resistant ovarian cancer | Failed | TBA | — |
Upcoming milestones
Ovarian cancer, Solid tumor/s, Cancer, Platinum-resistant ovarian cancer
DiscontinuedCompany profile
Mural Oncology plc is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.